Clinical Trial Update: A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death [Phase 1]

View source ↗

Summary

Phase 1 multicenter study evaluating whether mesenchymal stem cells can prevent rejection after kidney transplantation from donation after cardiac death.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Qipeng Sun | Conditions: Disorder Related to Renal Transplantation, Renal Transplant Rejection | Phase 1 | Status: UNKNOWN